Bardin Hill Management Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bardin Hill Management Partners’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-339,111	Closed	-$20.3M	–	47
2019 Q4	$20.3M	Buy	+339,111	New	+$12.7M	3.34%	11

Bardin Hill Management Partners's BOLD Position: Q1 2020 in Review

Bardin Hill Management Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 339,111 shares — an estimated $20.3M sold.

Bardin Hill Management Partners first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $20.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Bardin Hill Management Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Bardin Hill Management Partners sold 339,111 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $20.3M.
Bardin Hill Management Partners first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Bardin Hill Management Partners's Audentes Therapeutics, Inc position peaked at $20.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Bardin Hill Management Partners's 13F filing for Q1 2020, filed 15 May 2020.